Cargando…

Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways

Detalles Bibliográficos
Autores principales:	Pan, Hongda, Pan, Jingxin, Song, Shibo, Ji, Lei, Lv, Hong, Yang, Zhangru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063723/ https://www.ncbi.nlm.nih.gov/pubmed/33898326 http://dx.doi.org/10.3389/fonc.2021.670041

Ejemplares similares

EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2019)

Identification and development of long non‐coding RNA‐associated regulatory network in colorectal cancer
por: Pan, Hongda, et al.
Publicado: (2019)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Integrated Bioinformatic Investigation of EXOSCs in Hepatocellular Carcinoma Followed by the Preliminary Validation of EXOSC5 in Cell Proliferation
por: Zhang, Yujing, et al.
Publicado: (2022)

Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer
por: Pan, Hongda, et al.
Publicado: (2019)

EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways
por: Chen, Xiangliu, et al.
Publicado: (2022)

Prognostic Significance of Autophagy-Relevant Gene Markers in Colorectal Cancer
por: He, Qinglian, et al.
Publicado: (2021)

Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer
por: Zhang, Nannan, et al.
Publicado: (2020)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer
por: Pan, Hongda, et al.
Publicado: (2022)

High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer
por: Zhan, Zhao, et al.
Publicado: (2022)

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2021)

Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression
por: Zhang, Ding, et al.
Publicado: (2022)

Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesis
por: Knight, John R.P., et al.
Publicado: (2016)

EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023)

Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer
por: Xiao, Zilong, et al.
Publicado: (2023)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
por: Wang, Haowei, et al.
Publicado: (2022)

SPNS2 Downregulation Induces EMT and Promotes Colorectal Cancer Metastasis via Activating AKT Signaling Pathway
por: Lv, Lei, et al.
Publicado: (2021)

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer
por: Wei, Fang-Ze, et al.
Publicado: (2020)

Maspin as a Prognostic Marker for Early Stage Colorectal Cancer With Microsatellite Instability
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer
por: Okuno, Keisuke, et al.
Publicado: (2022)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)

Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways
por: Butler, Miriam, et al.
Publicado: (2022)

Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling
por: Wang, Wei, et al.
Publicado: (2021)

CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways
por: Wu, Qiong, et al.
Publicado: (2021)

LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer
por: Zhang, Li Hua, et al.
Publicado: (2019)

Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade
por: Yang, Qian, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer
por: Li, Qingshang, et al.
Publicado: (2020)

Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
por: Li, Bo, et al.
Publicado: (2021)

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
por: Bahl, Ankur, et al.
Publicado: (2020)

MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings
por: Li, Wei, et al.
Publicado: (2019)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models
por: Stulpinas, Aurimas, et al.
Publicado: (2023)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

PHF14 Promotes Cell Proliferation and Migration through the AKT and ERK1/2 Pathways in Gastric Cancer Cells
por: Zhao, Yuzu, et al.
Publicado: (2020)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

Corrigendum: A Weighted Gene Co-Expression Network Analysis–Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer
por: Chen, Qingchuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h4rvh4ceh91io7jchlrcv1hok